Новости и публикации
Information letter dated 07.10.2021 No. 01I-1295/21 About changing email addresses
The Federal Service for Surveillance in Healthcare, as part of the execution of the [...]
Safety variations for Ponatinib
After reviewing the available evidence and evaluating the evidence provided by the relevant Marketing [...]
Boequivalence studies
Bioequivalence (pharmacokinetic equivalence) is the degree of similarity of a pharmaceutically equivalent drug to [...]
National Pharmacovigilance Research Center took part in the XVII conference «Actual problems of ensuring the quality of drug and medical care»
On October 17-19, 2021, the XVII annual interregional conference "Actual problems of ensuring [...]
National Pharmacovigilance Research Center at the Eurasian Pharmaceutical Summit 2021
The Eurasian Pharmaceutical Summit was held on September 12-13, 2021. Our General Director, A.E. [...]
Medicinal product authorization
In order for a drug to enter the Russian market, it is required to [...]